Ep. 260, Chapter 5: U.S. Life Sciences Manufacturing and Funding with Jennifer Hawks Bland

43:40 – end

Bland discusses growing interest in bringing biomanufacturing back to New York state, noting that NewYorkBIO works with Empire State Development to attract these facilities, offering connections and support to integrate new companies into the local ecosystem. She emphasizes the need to balance reshoring efforts with ensuring worldwide patient access. Bland also addresses concerns about NIH funding cuts and highlights NewYorkBIO's role in connecting companies to existing grant opportunities while helping them navigate policy changes. Looking ahead, NewYorkBIO's priorities include continued advocacy on federal and state policies—from SBIR grant reauthorization to 340B drug pricing—and ecosystem enhancement through networking and resource development.